Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
BRCA2 A902fs*2
i
Other names:
BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast cancer 2, early onset
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
675
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
BRCA2 mutation (200)
BRCA wild-type (19)
BRCA1 mutation + BRCA2 mutation (4)
BRCA2 mutation + CHEK2 mutation (2)
BRCA2 mutation + TP53 mutation (2)
BRCA2 rearrangement (2)
APC mutation + BRCA2 mutation (1)
BRCA2 1153insT (1)
BRCA2 5396insC (1)
BRCA2 I2315T (1)
BRCA2 L557* (1)
BRCA2 N255fs + D252fs (1)
BRCA2 Y1655* + TP53 mutation (1)
BRCA2 biallelic inactivation (1)
BRCA2 mutation + ATM mutation (1)
BRCA2 mutation + CDK12 mutation (1)
BRCA2 mutation + SPOP mutation (1)
BRCA2 mutation + TP53 D816Y (1)
CHEK2 mutation + ATM mutation + BRCA2 mutation (1)
EGFR exon 19 deletion + BRCA2 mutation (1)
BRCA2 E260fs (0)
BRCA2 N255_R259delinsIK (0)
BRCA2 N255fs (0)
BRCA2 N255fs + BRCA2 N255_R259delinsIK + BRCA2 E260fs (0)
BRCA2 mutation (200)
BRCA wild-type (19)
BRCA1 mutation + BRCA2 mutation (4)
BRCA2 mutation + CHEK2 mutation (2)
BRCA2 mutation + TP53 mutation (2)
BRCA2 rearrangement (2)
APC mutation + BRCA2 mutation (1)
BRCA2 1153insT (1)
BRCA2 5396insC (1)
BRCA2 I2315T (1)
BRCA2 L557* (1)
BRCA2 N255fs + D252fs (1)
BRCA2 Y1655* + TP53 mutation (1)
BRCA2 biallelic inactivation (1)
BRCA2 mutation + ATM mutation (1)
BRCA2 mutation + CDK12 mutation (1)
BRCA2 mutation + SPOP mutation (1)
BRCA2 mutation + TP53 D816Y (1)
CHEK2 mutation + ATM mutation + BRCA2 mutation (1)
EGFR exon 19 deletion + BRCA2 mutation (1)
BRCA2 E260fs (0)
BRCA2 N255_R259delinsIK (0)
BRCA2 N255fs (0)
BRCA2 N255fs + BRCA2 N255_R259delinsIK + BRCA2 E260fs (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
BRCA2 A902fs*2
Prostate Cancer
BRCA2 A902fs*2
Prostate Cancer
abiraterone acetate + bicalutamide implant + leuprorelin depot
Resistant: C4 – Case Studies
abiraterone acetate + bicalutamide implant + leuprorelin depot
Resistant
:
C4
abiraterone acetate + bicalutamide implant + leuprorelin depot
Resistant: C4 – Case Studies
abiraterone acetate + bicalutamide implant + leuprorelin depot
Resistant
:
C4
BRCA2 A902fs*2
Prostate Cancer
BRCA2 A902fs*2
Prostate Cancer
cisplatin
Sensitive: C4 – Case Studies
cisplatin
Sensitive
:
C4
cisplatin
Sensitive: C4 – Case Studies
cisplatin
Sensitive
:
C4
BRCA2 A902fs*2
Prostate Cancer
BRCA2 A902fs*2
Prostate Cancer
docetaxel + cabazitaxel
Resistant: C4 – Case Studies
docetaxel + cabazitaxel
Resistant
:
C4
docetaxel + cabazitaxel
Resistant: C4 – Case Studies
docetaxel + cabazitaxel
Resistant
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login